110 related articles for article (PubMed ID: 28336365)
1. Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors.
Akrida I; Mulita F; Plachouri KM; Benetatos N; Maroulis I; Papadaki H
Med Oncol; 2023 Dec; 41(1):20. PubMed ID: 38104042
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer.
Brown MS; Abdollahi B; Wilkins OM; Lu H; Chakraborty P; Ognjenovic NB; Muller KE; Jolly MK; Christensen BC; Hassanpour S; Pattabiraman DR
Sci Adv; 2022 Aug; 8(31):eabj8002. PubMed ID: 35921406
[TBL] [Abstract][Full Text] [Related]
3. Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT).
Tangsiri M; Hheidari A; Liaghat M; Razlansari M; Ebrahimi N; Akbari A; Varnosfaderani SMN; Maleki-Sheikhabadi F; Norouzi A; Bakhtiyari M; Zalpoor H; Nabi-Afjadi M; Rahdar A
Biomed Pharmacother; 2024 Jan; 170():115973. PubMed ID: 38064969
[TBL] [Abstract][Full Text] [Related]
4. How important is EMT for cancer metastasis?
Celià-Terrassa T; Kang Y
PLoS Biol; 2024 Feb; 22(2):e3002487. PubMed ID: 38324529
[TBL] [Abstract][Full Text] [Related]
5. Indication of high lipid content in epithelial-mesenchymal transitions of breast tissues.
Sabtu SN; Sani SFA; Looi LM; Chiew SF; Pathmanathan D; Bradley DA; Osman Z
Sci Rep; 2021 Feb; 11(1):3250. PubMed ID: 33547362
[TBL] [Abstract][Full Text] [Related]
6. Identification of a core EMT signature that separates basal-like breast cancers into partial- and post-EMT subtypes.
Knutsen E; Das Sajib S; Fiskaa T; Lorens J; Gudjonsson T; Mælandsmo GM; Johansen SD; Seternes OM; Perander M
Front Oncol; 2023; 13():1249895. PubMed ID: 38111531
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid receptor: a harmonizer of cellular plasticity in breast cancer-directs the road towards therapy resistance, metastatic progression and recurrence.
Thakur D; Sengupta D; Mahapatra E; Das S; Sarkar R; Mukherjee S
Cancer Metastasis Rev; 2024 Mar; 43(1):481-499. PubMed ID: 38170347
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells and EMT in carcinoma.
Biddle A; Mackenzie IC
Cancer Metastasis Rev; 2012 Feb; ():. PubMed ID: 22302111
[TBL] [Abstract][Full Text] [Related]
9. Cellular Plasticity in Breast Cancer Progression and Therapy.
Kong D; Hughes CJ; Ford HL
Front Mol Biosci; 2020; 7():72. PubMed ID: 32391382
[TBL] [Abstract][Full Text] [Related]
10. Lineage Plasticity in Cancer: The Tale of a Skin-Walker.
Thankamony AP; Subbalakshmi AR; Jolly MK; Nair R
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298815
[TBL] [Abstract][Full Text] [Related]
11. Be like water, my cells: cell plasticity and the art of transformation.
Cammareri P; Myant KB
Front Cell Dev Biol; 2023; 11():1272730. PubMed ID: 37886398
[TBL] [Abstract][Full Text] [Related]
12. Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance.
Malik S; Sikander M; Wahid M; Dhasmana A; Sarwat M; Khan S; Cobos E; Yallapu MM; Jaggi M; Chauhan SC
Cancer Metastasis Rev; 2024 Mar; ():. PubMed ID: 38498072
[TBL] [Abstract][Full Text] [Related]
13. Oncosis and apoptosis induction by activation of an overexpressed ion channel in breast cancer cells.
Peters AA; Jamaludin SYN; Yapa KTDS; Chalmers S; Wiegmans AP; Lim HF; Milevskiy MJG; Azimi I; Davis FM; Northwood KS; Pera E; Marcial DL; Dray E; Waterhouse NJ; Cabot PJ; Gonda TJ; Kenny PA; Brown MA; Khanna KK; Roberts-Thomson SJ; Monteith GR
Oncogene; 2017 Nov; 36(46):6490-6500. PubMed ID: 28759041
[TBL] [Abstract][Full Text] [Related]
14. Impairment of cell adhesion and migration by inhibition of protein disulphide isomerases in three breast cancer cell lines.
Young HS; McGowan LM; Jepson KA; Adams JC
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33095243
[TBL] [Abstract][Full Text] [Related]
15. Predictive Value of Pin1 in Cervical Low-Grade Squamous Intraepithelial Lesions and Inhibition of Pin1 Exerts Potent Anticancer Activity against Human Cervical Cancer.
Guo YT; Lu Y; Jia YY; Qu HN; Qi D; Wang XQ; Song PY; Jin XS; Xu WH; Dong Y; Liang YY; Quan CS
Aging Dis; 2020 Feb; 11(1):44-59. PubMed ID: 32010480
[TBL] [Abstract][Full Text] [Related]
16. Baicalein inhibits fibronectin-induced epithelial-mesenchymal transition by decreasing activation and upregulation of calpain-2.
Chen Y; Chen L; Hong D; Chen Z; Zhang J; Fu L; Pan D; Zhang Y; Xu Y; Gan S; Xiao C; Tao L; Shen X
Cell Death Dis; 2019 Apr; 10(5):341. PubMed ID: 31000696
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA (LncRNA) HOXA11-AS Promotes Breast Cancer Invasion and Metastasis by Regulating Epithelial-Mesenchymal Transition.
Li W; Jia G; Qu Y; Du Q; Liu B; Liu B
Med Sci Monit; 2017 Jul; 23():3393-3403. PubMed ID: 28701685
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer cells: Focus on the consequences of epithelial-to-mesenchymal transition.
Bong AHL; Monteith GR
Int J Biochem Cell Biol; 2017 Jun; 87():23-26. PubMed ID: 28336365
[TBL] [Abstract][Full Text] [Related]
19. Manganese Superoxide Dismutase Expression Regulates the Switch Between an Epithelial and a Mesenchymal-Like Phenotype in Breast Carcinoma.
Loo SY; Hirpara JL; Pandey V; Tan TZ; Yap CT; Lobie PE; Thiery JP; Goh BC; Pervaiz S; Clément MV; Kumar AP
Antioxid Redox Signal; 2016 Aug; 25(6):283-99. PubMed ID: 27400860
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
